Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1986;6:357-377

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldbourt, U.
Right arrow Articles by Neufeld, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldbourt, U.
Right arrow Articles by Neufeld, H. N.

Arteriosclerosis, Vol 6, 357-377, Copyright © 1986 by American Heart Association


REVIEW

Genetic aspects of arteriosclerosis

U Goldbourt and HN Neufeld

This review discusses the genetic factors in the development of arteriosclerosis and coronary heart disease (CHD). In several studies, multivariate analysis of prospective mortality/morbidity data and angiographic findings have indicated that a family history of CHD contributed to CHD risk independently of the established risk factors. In addition, ethnic groups that differ in the prevalence and incidence of CHD also markedly differ in blood groups and protein-enzymatic markers. These or other genetic differences may affect CHD rates. Data from fraternal and identical twins, the source of some early genetic CHD findings, are reviewed. Genetic disorders of lipoprotein metabolism and transport, such as familial hypercholesterolemia, as well as other monogenic disorders are discussed. The role of apoprotein E polymorphism i other monogenic disorders are discussed. The role of apoprotein E polymorphism in determining plasma LDL variability among individuals is considered. Recombinant DNA technology, molecular cloning, and the identification of restriction fragment length polymorphisms are new tools for investigators who assess DNA polymorphism. Recent advances in that domain include: DNA polymorphisms affecting blood levels of apo A-I and A-II, association of a DNA insertion on chromosome 19 with severe premature atherosclerosis, and information concerning linkage of the genes for various apolipoproteins. In addition, the evidence for a major genetic component in diabetes mellitus and research into the genetic aspects of hypertension are reviewed. The male/female ratio in pathologically and epidemiologically assessed atherosclerosis may provide clues to the role of genetics. Early structural changes in the coronary artery intima are compatible with the ethnic and gender predilection. A key question in understanding underlying mechanisms in atherosclerosis is why coronary arteries are occluded in individuals whose other arterial systems are largely unaffected. The review concludes with a discussion of the directions and implications of future genetic research in arteriosclerosis with an emphasis on uncovering genetically determined differences in arterial wall response to blood flow. Subpopulations with different genetic risks may be identified, in which case universal preventive strategies might be replaced with specific ones.


This article has been cited by other articles:


Home page
ICVTSHome page
A. U. Gullu, M. Kizilay, M. Ates, and M. Akcar
The comparison of angiographic lesions and clinical outcomes in identical twins
Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 575 - 576.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. P. Faxon, V. Fuster, P. Libby, J. A. Beckman, W. R. Hiatt, R. W. Thompson, J. N. Topper, B. H. Annex, J. H. Rundback, R. P. Fabunmi, et al.
Atherosclerotic Vascular Disease Conference: Writing Group III: Pathophysiology
Circulation, June 1, 2004; 109(21): 2617 - 2625.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Aucella, M. Margaglione, M. Vigilante, G. Gatta, E. Grandone, M. Forcella, M. Ktena, A. De Min, G. Salatino, D. A. Procaccini, et al.
PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis
Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1142 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. J. Valentine, R. Verstraete, G. P. Clagett, and J. C. Cohen
Premature Cardiovascular Disease Is Common in Relatives of Patients With Premature Peripheral Atherosclerosis
Arch Intern Med, May 8, 2000; 160(9): 1343 - 1348.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. U. Gerdes, C. Gerdes, K. Kervinen, M. Savolainen, I. C. Klausen, P. S. Hansen, Y. A. Kesaniemi, and O. Fargeman
The Apolipoprotein {epsilon}4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction : A Substudy of the Scandinavian Simvastatin Survival Study
Circulation, March 28, 2000; 101(12): 1366 - 1371.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Margaglione, G. Cappucci, D. Colaizzo, G. Vecchione, E. Grandone, and G. Di Minno
C-Reactive Protein in Offspring Is Associated With the Occurrence of Myocardial Infarction in First-Degree Relatives
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 198 - 203.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Francis, N. J. Camp, R. M. Dewberry, J. Gunn, P. Syrris, N. D. Carter, S. Jeffery, J. C. Kaski, D. C. Cumberland, G. W. Duff, et al.
Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease
Circulation, February 23, 1999; 99(7): 861 - 866.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Gu, M. W. Johnson, and A. J. Lusis
Quantitative Trait Locus Analysis of Plasma Lipoprotein Levels in an Autoimmune Mouse Model : Interactions Between Lipoprotein Metabolism, Autoimmune Disease, and Atherogenesis
Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 442 - 453.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Tanne, S. Yaari, and U. Goldbourt
Risk Profile and Prediction of Long-Term Ischemic Stroke Mortality : A 21-Year Follow-up in the Israeli Ischemic Heart Disease (IIHD) Project
Circulation, October 6, 1998; 98(14): 1365 - 1371.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Jousilahti, D. Rastenyte, J. Tuomilehto, C. Sarti, and E. Vartiainen
Parental History of Cardiovascular Disease and Risk of Stroke : A Prospective Follow-up of 14 371 Middle-aged Men and Women in Finland
Stroke, July 1, 1997; 28(7): 1361 - 1366.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Thiery, K. Nebendahl, K. Rapp, R. Kluge, D. Teupser, and D. Seidel
Low Atherosclerotic Response of a Strain of Rabbits to Diet-Induced Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1181 - 1188.
[Abstract] [Full Text]


Home page
NEJMHome page
M. E. Marenberg, N. Risch, L. F. Berkman, B. Floderus, and U. de Faire
Genetic Susceptibility to Death from Coronary Heart Disease in a Study of Twins
N. Engl. J. Med., April 14, 1994; 330(15): 1041 - 1046.
[Abstract] [Full Text]